On 1 July 1994, a special board, the Gene Technology Advisory Board, was established. The Gene Technology Advisory Board is to monitor developments in the field of gene technology, oversee ethical issues, and give advice on use of gene technology. The Board accordingly has an overall responsibility in the field of gene technology.
According to its instructions (2007:1075), the Board is to promote an ethically defensible and safe use of gene technology by the provision of advice, so that the health of people and animals is safeguarded. The Board shall in that connection take into consideration the importance of maintaining a good research policy climate.
The Board shall keep abreast of the national and international developments in the field of gene technology, in order to be able to evaluate the effect of new applications of gene technology on health and the environment and to be able to make an ethical assessment of new aspects of development.
The Board also has the task of disseminating knowledge about developments in gene technology. It shall further notify the Government if any area of use or planned area of use of gene technology can be called into question from an ethical or humanitarian point of view, or if the area for public supervision needs to be expanded to include other matters than those at present subject to public control.
The Board makes statements on applications for consent pursuant to the Act concerning Genetically Modified Organisations and consults the supervisory authorities when regulations are notified pursuant to the act. The EEA agreement and membership of the EU also entail that statements are made on applications for intentional placement of genetically modified organisms and release on the market of such products in other countries within the EU.